Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Published on by Academic Awards

Prof. Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Prof. Chyi-Liang Chen, Linkou Chang Gung Memorial Hospital Children’s Medical Center, Taiwan

🧬 Prof. Chyi-Liang Chen is an Associate Researcher at Chang Gung Memorial Hospital and the Department of Microbiology and Immunology, Chang Gung University, Taiwan. He earned his BSc, MSc, and PhD in Life Sciences from National Chung Hsing University. With extensive postdoctoral research at Chang Gung University and the University of Calgary, his expertise spans microbiology, molecular microbiology, protein engineering, bacterial genomics, and antimicrobial resistance. He has authored numerous SCIE-indexed publications on bacterial pathogenesis and genetic engineering. His work contributes to biotechnology, genomics, and patent applications, advancing microbial research. 🦠🔬📚

Publication Profile

Scopus

Orcid

🎓 Educational Background

Prof. Chyi-Liang Chen pursued his academic journey in Life Sciences at National Chung Hsing University, Taiwan. He obtained his Bachelor’s degree (1984–1988) from the Department of Life Sciences (formerly the Department of Botany). He then completed his Master’s degree (1988–1990) at the Institute of Life Sciences (previously the Institute of Botany Microbiome). Further advancing his expertise, he earned a Ph.D. (1990–1995) from the same institute. His strong foundation in microbiology, molecular biology, and botany has significantly contributed to his impactful research in bacterial genomics and biotechnology. 🧬🔬📖

🏅 Professional Experience

Prof. Chyi-Liang Chen has an extensive career in microbiology and immunology. He began as a Postdoctoral Fellow at Chang Gung University, Taiwan (1997–1999) before moving to the University of Calgary, Canada (1999–2002). He later returned to Chang Gung University (2002–2006). He served as an Assistant Professor at Yuanzhi University and later as an Assistant Researcher at Chang Gung Memorial Hospital (2006–2012). Since 2012, he has been an Associate Researcher at Chang Gung Memorial Hospital and, from 2022, also at the Department of Microbiology and Immunology, Chang Gung University. 🧪🔬📚

🔬 Research Focus

Prof. Chyi-Liang Chen specializes in infectious diseases, microbiology, and immunology. His research spans viral infections 🦠, antimicrobial resistance 💊, and host-pathogen interactions 🏥. He has contributed to studies on multiple viral infections in children, cytomegalovirus colitis, and antiviral treatments. His work also explores the gut microbiota’s role in cancer therapy and cross-species microRNAs. Additionally, he has investigated COVID-19 therapeutics 😷 and SARS-CoV-2 variants 🧬. His studies provide crucial insights into infectious disease management, making significant contributions to global health and microbiological research. 🌍🔍

Publication Top Notes

1️⃣ Multiple viral infections and antimicrobial use in hospitalized children with respiratory illness during pandemic and early post-pandemic era, Taiwan 🦠💊 (Heliyon, 2025) 
2️⃣ Identifying the function of novel cross-species microRNAs from the excretory-secretory products of Angiostrongylus cantonensis fifth-stage larvae 🧬🦠 (Journal of Microbiology, Immunology and Infection, 2025) 
3️⃣ Maternal Infections, Antibiotics, Steroid Use, and Diabetes Mellitus Increase Risk of Early-Onset Sepsis in Preterm Neonates 🤰🦠 (Pathogens, 2025) 
4️⃣ Adequate antiviral treatment lowers overall complications of cytomegalovirus colitis among inpatients with inflammatory bowel diseases 💊🦠 (BMC Infectious Diseases, 2024) – 2 citations
5️⃣ Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer 🦠🧪 (Biomedical Journal, 2024) – 5 citations
6️⃣ Antimicrobial activity of eravacycline and other comparative agents on aerobic and anaerobic bacterial pathogens in Taiwan 💊🦠 (Journal of Global Antimicrobial Resistance, 2024) – 1 citation
7️⃣ Complete genome sequence of Bacillus halotolerans F29-3, a fengycin-producing strain 🧬🦠 (Microbiology Resource Announcements, 2024) 
8️⃣ Cytomegalovirus Diseases of the Gastrointestinal Tract in Immunocompetent Patients: A Narrative Review 🦠📖 (Viruses, 2024) – 5 citations
9️⃣ Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients 💉🦠 (Human Vaccines and Immunotherapeutics, 2024) 
🔟 Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives 🦠💉 (Journal of the Formosan Medical Association, 2024) – 1 citation

Conclusion

Prof. Chyi-Liang Chen is highly suitable for the Best Researcher Award due to his strong academic background, international research experience, expertise in microbiology and bacterial pathogenesis, and high-impact publications. His work has significantly advanced molecular microbiology and biotechnology, making him a worthy candidate for this prestigious recognition.

Timothy Waje | Medical Microbiology | Best Researcher Award

Published on by Academic Awards

Mr Timothy Waje | Medical Microbiology | Best Researcher Award

Timothy Waje At Abubakar Tafawa Balewa University Bauchi

Dr. Timothy Waje is a dedicated medical microbiologist with expertise in infectious disease epidemiology, public health research, and capacity development. With extensive experience in academic leadership, consultancy, and community health programs, he combines scientific rigor with a commitment to improving global health outcomes. Dr. Waje aspires to become a professor in medical microbiology, contributing to vaccine development and solutions for viral and bacterial health challenges.

Publication Profile

Education

Dr. Timothy Waje is currently pursuing a Doctor of Philosophy (Ph.D.) in Medical Microbiology at Abubakar Tafawa Balewa University, Bauchi, Nigeria. He holds a Master of Science (M.Sc.) in Medical Microbiology from Kaduna State University, Kaduna, Nigeria, completed in 2018 with a commendable CGPA of 4.60/5.00. His undergraduate degree, a Bachelor of Technology (B.Tech Hons) in Applied Microbiology, was also earned at Abubakar Tafawa Balewa University in 1998, graduating with a CGPA of 4.10/5.00. His academic training includes advanced courses in medical microbiology, epidemiology, biostatistics, and research methodology.

Professional Experience 🌟

Dr. Waje currently serves as the Provost of Lodestar School of Health and Technology, Kujama, Kaduna State, where he oversees administrative, academic, and operational functions. His role includes staff training, recruitment, and liaison with government and professional bodies, in addition to teaching microbiology and communicable disease control.

Previously, he has held consultancy roles with Sightsavers Nigeria, contributing to neglected tropical disease programs such as lymphatic filariasis and trachoma elimination. His work involved community mobilization, data management, field supervision, and training health workers. With over a decade of experience in the banking sector, he held managerial positions at Access Bank Plc and United Bank for Africa, where he honed his leadership, compliance, and team-building skills.

Research Interests:

Dr. Waje’s research interests focus on infectious disease epidemiology, particularly in vaccine research and development for common pathogens. He is dedicated to exploring molecular epidemiology, the genomic relationship between viruses and drug responses, and the intersection of viral replication, host cell inflammation, and related symptoms. His work also extends to improving emergency preparedness for viral disease outbreaks and human capacity development for future scientists.

Research Contributions:

Dr. Waje has authored multiple publications in peer-reviewed journals, including studies on cytomegalovirus, lymphatic filariasis, and genetic diversity in Campylobacter species. Notable works include:

  1. Occurrence of Cytomegalovirus Among Pregnant Antenatal Women Within Bauchi Metropolis, Nigeria (Clinical Epidemiology and Global Health, 2025).
  2. A Review of Epidemiology of Lymphatic Filariasis in Nigeria (Pan African Medical Journal, 2024).
  3. Genetic Diversity, Virulence, and Resistance Genes Among Campylobacter Species in Nigeria: A Review (Current Clinical Microbiology Reports, 2024).

Metrics and Memberships:

Dr. Waje’s research outputs are recognized internationally, with publications indexed in high-impact journals. He is an active member of the American Society for Microbiology (Global Outreach Membership) and the International Society for Infectious Diseases (ISID).

Publication Top Notes

1. Occurrence of Cytomegalovirus among Pregnant Antenatal Women within Bauchi Metropolis, Nigeria

  • Authors: Waje, T., Iliyasu, M.Y., Umar, A.F., Agbo, E.B.
  • Journal: Clinical Epidemiology and Global Health (2025), Volume 32, Article 101915.
  • Summary: This article investigates the prevalence of Cytomegalovirus (CMV) infection among pregnant women in Bauchi, Nigeria. It highlights the epidemiological significance of CMV in antenatal care and provides insights into its potential impact on maternal and fetal health.
  • Citations: None reported.

2. Occurrence of Genetic Diversity, Virulence, and Resistance Genes Among Campylobacter Species in Nigeria: A Review

  • Authors: Waje, T., Iliyasu, C., Yaki, L.M., Auta, I.K.
  • Journal: Current Clinical Microbiology Reports (2024), Volume 11, Issue 2, Pages 35–42.
  • Summary: This review examines the genetic diversity, virulence factors, and antimicrobial resistance genes in Campylobacter species identified in Nigeria. It emphasizes the importance of molecular surveillance for improving public health strategies against Campylobacter-associated infections.
  • Citations: None reported.

3. A Review of Epidemiology of Lymphatic Filariasis in Nigeria

  • Authors: Waje, T., Iliyasu, C., Yaki, L.M., Auta, I.K.
  • Type: Review (Open Access)
  • Summary: This paper reviews the epidemiological aspects of lymphatic filariasis in Nigeria, including its prevalence, transmission, control measures, and public health challenges. The article aims to provide comprehensive data to guide eradication programs in endemic regions.

Conclusion

Dr. Timothy Waje’s outstanding contributions to medical microbiology, leadership, and dedication to improving public health make him a compelling candidate for the Best Researcher Award. His work demonstrates a balance of academic rigor and practical application, particularly in addressing infectious diseases that impact vulnerable populations.

By addressing areas for improvement, such as enhancing research visibility and fostering international collaboration, Dr. Waje can further solidify his position as a leading figure in medical microbiology. Recognizing his achievements with this award would not only honor his contributions but also inspire continued excellence in the field.